Smoking prevention intervention with school classes in university hospital by thoracic surgeon und pulmonologist. The Zurich prevention project

por Furrer, K., Schuurmans, M.M., Hebeisen, M., Schulte, S., Schneiter, D., Weder, W., Opitz, I., Hillinger, S.
Publicado 2022

CD74: a new prognostic factor for patients with malignant pleural mesothelioma

por Otterstrom, C, Soltermann, A, Opitz, I, Felley-Bosco, E, Weder, W, Stahel, R A, Triponez, F, Robert, J H, Serre-Beinier, V
Publicado 2014

FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patients

por Pavic, M., Bogowicz, M., Kraft, J., Vuong, D., Mayinger, M., Kroeze, S. G. C., Friess, M., Frauenfelder, T., Andratschke, N., Huellner, M., Weder, W., Guckenberger, M., Tanadini-Lang, S., Opitz, I.
Publicado 2020

Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials

por König, D., Schär, S., Vuong, D., Guckenberger, M., Furrer, K., Opitz, I., Weder, W., Rothschild, S.I., Ochsenbein, A., Zippelius, A., Addeo, A., Mark, M., Eboulet, E.I., Hayoz, S., Thierstein, S., Betticher, D.C., Ris, H.-B., Stupp, R., Curioni-Fontecedro, A., Peters, S., Pless, M., Früh, M.
Publicado 2022

Neoadjuvant treatment does not influence PD-L1 expression in stage III non-small-cell lung cancer: a retrospective analysis of tumor samples from the trials SAKK 16/96, 16/00, 16/0...

por König, D., Savic Prince, S., Hayoz, S., Zens, P., Berezowska, S., Jochum, W., Stauffer, E., Braunersreuther, V., Trachsel, B., Thierstein, S., Mark, M., Schmid, S., Curioni-Fontecedro, A., Addeo, A., Opitz, I., Guckenberger, M., Früh, M., Betticher, D.C., Ris, H.-B., Stupp, R., Rothschild, S.I., Bubendorf, L., Pless, M.
Publicado 2023